DK3909568T3 - Profylaktisk eller terapeutisk lægemiddel til neurodegenerative lidelser - Google Patents

Profylaktisk eller terapeutisk lægemiddel til neurodegenerative lidelser Download PDF

Info

Publication number
DK3909568T3
DK3909568T3 DK20738553.5T DK20738553T DK3909568T3 DK 3909568 T3 DK3909568 T3 DK 3909568T3 DK 20738553 T DK20738553 T DK 20738553T DK 3909568 T3 DK3909568 T3 DK 3909568T3
Authority
DK
Denmark
Prior art keywords
prophylactic
therapeutic agent
neurodegenerative disorders
neurodegenerative
disorders
Prior art date
Application number
DK20738553.5T
Other languages
English (en)
Inventor
Takami Tomiyama
Tomohiro Umeda
Toru Kumagai
Original Assignee
Medilabo Rfp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medilabo Rfp Inc filed Critical Medilabo Rfp Inc
Application granted granted Critical
Publication of DK3909568T3 publication Critical patent/DK3909568T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11Plant sterols or derivatives thereof, e.g. phytosterols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK20738553.5T 2019-01-09 2020-01-09 Profylaktisk eller terapeutisk lægemiddel til neurodegenerative lidelser DK3909568T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2019/000278 WO2020144753A1 (ja) 2019-01-09 2019-01-09 神経変性疾患の予防又は治療薬
PCT/JP2020/000392 WO2020145331A1 (ja) 2019-01-09 2020-01-09 神経変性疾患の予防又は治療薬

Publications (1)

Publication Number Publication Date
DK3909568T3 true DK3909568T3 (da) 2024-09-30

Family

ID=71520264

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20738553.5T DK3909568T3 (da) 2019-01-09 2020-01-09 Profylaktisk eller terapeutisk lægemiddel til neurodegenerative lidelser

Country Status (16)

Country Link
US (2) US12521387B2 (da)
EP (1) EP3909568B1 (da)
JP (1) JP7279958B2 (da)
KR (1) KR102896709B1 (da)
CN (1) CN113260357B (da)
BR (1) BR112021013582A2 (da)
CA (1) CA3125913A1 (da)
DK (1) DK3909568T3 (da)
ES (1) ES2989515T3 (da)
FI (1) FI3909568T3 (da)
HU (1) HUE069327T2 (da)
MX (1) MX2021008329A (da)
PL (1) PL3909568T3 (da)
PT (1) PT3909568T (da)
TW (1) TWI833874B (da)
WO (2) WO2020144753A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same
WO2025225629A1 (ja) * 2024-04-23 2025-10-30 株式会社メディラボRfp 経鼻投与用組成物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004222529A1 (en) * 2003-03-19 2004-09-30 Ares Trading S.A. INF-beta alone or in combination with other medicaments for treating Alzheimer's disease and demens disorders
EP1850840A2 (en) 2005-01-13 2007-11-07 Sirtris Pharmaceuticals, Inc. Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
US20070014833A1 (en) 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
EP2805719A1 (en) 2005-03-30 2014-11-26 Glaxosmithkline LLC Nicotinamide riboside and analogues thereof
US20060292099A1 (en) 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
US20070149466A1 (en) 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
US7837832B2 (en) 2005-12-15 2010-11-23 Dow Global Technologies, Inc. Additive compositions for treating various base sheets
US7842163B2 (en) 2005-12-15 2010-11-30 Kimberly-Clark Worldwide, Inc. Embossed tissue products
US7803250B2 (en) 2005-12-15 2010-09-28 Dow Global Technologies, Inc. Wiping products having enhanced cleaning abilities
US7803249B2 (en) 2005-12-15 2010-09-28 Dow Global Technologies Inc. Wiping products with controlled lint properties
US7879188B2 (en) 2005-12-15 2011-02-01 Kimberly-Clark Worldwide, Inc. Additive compositions for treating various base sheets
US20070137811A1 (en) 2005-12-15 2007-06-21 Kimberly-Clark Worldwide, Inc. Premoistened tissue products
US7678231B2 (en) 2005-12-15 2010-03-16 Dow Global Technologies, Inc. Process for increasing the basis weight of sheet materials
US8282776B2 (en) 2005-12-15 2012-10-09 Kimberly-Clark Worldwide, Inc. Wiping product having enhanced oil absorbency
US7879191B2 (en) 2005-12-15 2011-02-01 Kimberly-Clark Worldwide, Inc. Wiping products having enhanced cleaning abilities
US7879189B2 (en) 2005-12-15 2011-02-01 Kimberly-Clark Worldwide, Inc. Additive compositions for treating various base sheets
US7807023B2 (en) 2005-12-15 2010-10-05 Kimberly-Clark Worldwide, Inc. Process for increasing the basis weight of sheet materials
US8444811B2 (en) 2005-12-15 2013-05-21 Kimberly-Clark Worldwide, Inc. Process for increasing the basis weight of sheet materials
US7883604B2 (en) 2005-12-15 2011-02-08 Kimberly-Clark Worldwide, Inc. Creping process and products made therefrom
US7837831B2 (en) 2005-12-15 2010-11-23 Kimberly-Clark Worldwide, Inc. Tissue products containing a polymer dispersion
US7820010B2 (en) 2005-12-15 2010-10-26 Kimberly-Clark Worldwide, Inc. Treated tissue products having increased strength
US20080075671A1 (en) 2006-09-22 2008-03-27 Di Mauro Thomas M Intranasally administering curcumin to the brain to treat alzheimer's disease
US20090087385A1 (en) 2006-09-22 2009-04-02 Di Mauro Thomas M Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease
EP2749552B1 (en) 2007-04-17 2015-11-18 Codman & Shurtleff, Inc. Curcumin-resveratrol hybrids
US8383865B2 (en) 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
GB2463833B (en) * 2007-06-26 2012-02-08 Parkinson S Inst Compositions that prevent or reverse alpha-synuclein fibrillation for use in the treatment of neurological disorders
US7745670B2 (en) 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
US20090324740A1 (en) * 2008-06-13 2009-12-31 Albritton Iv Ford D Novel nasal spray
US7985776B2 (en) 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
GB2480159A (en) * 2008-11-14 2011-11-09 Parkinson S Inst Compositions and methods for the treatment of altered a-synuclein function
WO2010095926A1 (en) * 2009-02-20 2010-08-26 N.V. Nutricia Use of reveratrol for preserving cognitive functioning
JP2013518034A (ja) * 2010-01-21 2013-05-20 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 薬物として使用するための特別な組成物
BRPI1001052A2 (pt) * 2010-04-22 2011-12-13 União Brasileira De Educação E Assistência - Mantenedora Da Puc Rs formulação farmacêutica e processo para reduzir hepatotoxicidade
US20120058088A1 (en) 2010-06-28 2012-03-08 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Methods Of Use
WO2012054936A1 (en) 2010-10-22 2012-04-26 Barber Elizabeth K Treatment of neurodegenerative disease

Also Published As

Publication number Publication date
CN113260357A (zh) 2021-08-13
BR112021013582A2 (pt) 2021-09-21
EP3909568A4 (en) 2022-07-27
WO2020145331A1 (ja) 2020-07-16
US20260102392A1 (en) 2026-04-16
US20220125782A1 (en) 2022-04-28
PT3909568T (pt) 2024-10-17
CN113260357B (zh) 2024-11-15
KR102896709B1 (ko) 2025-12-08
PL3909568T3 (pl) 2025-01-20
EP3909568B1 (en) 2024-09-18
HUE069327T2 (hu) 2025-02-28
EP3909568A1 (en) 2021-11-17
TW202042793A (zh) 2020-12-01
WO2020144753A1 (ja) 2020-07-16
JPWO2020145331A1 (ja) 2021-11-25
US12521387B2 (en) 2026-01-13
CA3125913A1 (en) 2020-07-16
ES2989515T3 (es) 2024-11-26
KR20210113240A (ko) 2021-09-15
JP7279958B2 (ja) 2023-05-23
FI3909568T3 (fi) 2024-10-08
MX2021008329A (es) 2021-08-05
TWI833874B (zh) 2024-03-01

Similar Documents

Publication Publication Date Title
DK4088720T3 (da) Rimegepant til cgrp-relaterede lidelser
DK4061344T3 (da) 6-hydroxycannabidiol til anvendelse som lægemiddel
DK3600281T3 (da) Kombinationsbehandling til behandling eller forebyggelse af tumorer
DK3383363T3 (da) Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande
DK3253382T3 (da) Farmaceutiske sammensætninger til kombinationsterapi
IL270916A (en) Combined therapy for nmdar antagonist-responsive neuropsychiatric disorders
LT3416631T (lt) Terapiniai agentai, skirti neurodegeneracinių ligų gydymui
DK4445958T3 (da) Kombinationsterapi til melanom
EP4067741C0 (de) Feuersäule
DK3740504T3 (da) CD70 kombinationsterapi
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
KR101899102B9 (ko) 자동 소화 장치
IL255185A0 (en) 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto
DK3380471T3 (da) Tetrahydro-8h-pyrido[1,2-a]pyrazin-8-oner som comt-inhibitorer til behandlingen af neurodegenerative lidelser
EP3573614C0 (en) PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
IL282114A (en) Processes for preparing functionalized cyclooctenes
IL269853A (en) Proteins for the treatment of epithelial barrier activity disorders
DK3430143T3 (da) Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme
DK3348260T3 (da) Farmaceutisk tramadol-sammensætning til oftalmisk anvendelse
DK3724173T3 (da) Forbindelser til behandling af neuromuskulære lidelser
DK3773595T3 (da) Farmaceutiske anticancer-sammensætninger til kombineret terapi
EP3730141A4 (en) THERAPEUTIC FOR NIGHTLY POLLAKISURIA
IL280227A (en) Arimoclomol for treating glucocerebrosidase associated disorders
IL280441A (en) Sulfopropanoic acid derivatives for treating neurodegenerative disorders